Complete Filing Data
Horizon Space Acquisition II Corp. reported Stockholders Equity of $0.00 for FY2023.
All values from 10-K, 20-F, and 10-Q filings on SEC EDGAR, organized by financial statement. Scroll each table horizontally for the full history. Blank cells mean Horizon Space Acquisition II Corp. did not report that metric for that period in XBRL — often because accounting standards changed which tag a company files under (for example, most companies moved revenue to the ASC-606 tag in 2018), so a metric may continue in a different row. Rows marked * merge those successor tags into one continuous series, preferring the audited value from the newest-standard tag where periods overlap.
Income Statement
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2024 |
|---|---|
| Net Income * | $142.9K |
| Income Loss From Continuing Operations | -$201.7K |
| Income Tax Expense Benefit | $0.00 |
| Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest | $142.9K |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 |
|---|---|---|---|---|---|---|---|---|
| Net Income * | $615.0K | $221.3K | $472.6K | -$33.6K | -$8.0K | -$3.1K | $0.00 | -$4.3K |
| Income Loss From Continuing Operations | -$124.5K | -$509.2K | -$253.5K | -$33.6K | -$8.0K | -$3.1K | ||
| Income Tax Expense Benefit | ||||||||
| Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest |
Balance Sheet
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2024 | FY2023 |
|---|---|---|
| Stockholders Equity | $0.00 | |
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | $0.00 | |
| Retained Earnings Accumulated Deficit | -$4.3K | |
| Preferred Stock Value | $0.00 | |
| Liabilities Current | $4.3K | |
| Liabilities And Stockholders Equity | $0.00 | |
| Liabilities | $4.3K | |
| Common Stock Value | $173.00 | |
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect | $646.7K | |
| Assets Current | $0.00 | |
| Assets | $0.00 | |
| Other Accounts Payable And Accrued Liabilities | $4.3K | |
| Cash Equivalents At Carrying Value | $0.00 | |
| Assets Held In Trust | $0.00 | |
| Accrued Liability Expenses Paid By Sponsor | $129.1K | |
| Deferred Offering Costs Paid By Sponsor For Settlements Of Subscriptions Receivables | $25.0K | |
| Deferred Offering Costs Paid By Sponsor | $125.4K | |
| Subscriptions Receivable | ||
| Stockholders Equity Note Subscriptions Receivable | ||
| Long Term Notes Payable | ||
| Deferred Costs | ||
| Common Stock Shares Subscriptions Receivable | 0.00 | -25.0K |
| Commitments And Contingencies | $0.00 | $0.00 |
| Accrued Liabilities Current | ||
| Received Proceed From Subscription Receivable | $25.0K |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 |
|---|---|---|---|---|---|---|---|---|---|---|
| Stockholders Equity | -$436.3K | -$311.8K | $197.4K | $450.9K | -$24.0K | -$9.6K | -$7.4K | -$4.3K | -$4.3K | -$4.3K |
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | $66.6K | $26.0K | $364.8K | $646.7K | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | |
| Retained Earnings Accumulated Deficit | -$436.5K | -$312.0K | $197.2K | $138.6K | -$49.0K | |||||
| Preferred Stock Value | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | |||||
| Liabilities Current | $558.8K | $427.9K | $291.7K | $269.3K | $216.9K | |||||
| Liabilities And Stockholders Equity | $71.7M | $70.9M | $70.6M | $70.1M | $192.9K | |||||
| Liabilities | $558.8K | $427.9K | $291.7K | $269.3K | $216.9K | |||||
| Common Stock Value | $218.00 | $218.00 | $218.00 | $218.00 | $173.00 | |||||
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect | -$281.9K | $0.00 | ||||||||
| Assets Current | $122.5K | $116.1K | $489.0K | $720.2K | $41.2K | |||||
| Assets | $71.7M | $70.9M | $70.6M | $70.1M | $192.9K | |||||
| Other Accounts Payable And Accrued Liabilities | $4.3K | $173.4K | $37.2K | $14.9K | ||||||
| Cash Equivalents At Carrying Value | $66.6K | $26.0K | $364.8K | $646.7K | ||||||
| Assets Held In Trust | $71.5M | $70.8M | $70.1M | $69.3M | ||||||
| Accrued Liability Expenses Paid By Sponsor | ||||||||||
| Deferred Offering Costs Paid By Sponsor For Settlements Of Subscriptions Receivables | ||||||||||
| Deferred Offering Costs Paid By Sponsor | ||||||||||
| Subscriptions Receivable | $25.0K | |||||||||
| Stockholders Equity Note Subscriptions Receivable | $0.00 | $25.0K | ||||||||
| Long Term Notes Payable | $300.0K | $0.00 | ||||||||
| Deferred Costs | $151.7K | $0.00 | ||||||||
| Common Stock Shares Subscriptions Receivable | ||||||||||
| Commitments And Contingencies | ||||||||||
| Accrued Liabilities Current | $19.7K | $4.3K | ||||||||
| Received Proceed From Subscription Receivable |
Cash Flow Statement
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2024 |
|---|---|
| Net Cash Provided By Used In Operating Activities | -$110.5K |
| Increase Decrease In Accrued Liabilities | $164.7K |
| Increase Decrease In Prepaid Expense | $73.5K |
| Net Cash Provided By Used In Financing Activities | $69.8M |
| Proceeds From Sale Of Private Placement Units Including Over Allotment | $2.1M |
| Proceeds From Sale Of Longterm Investments | $68.0M |
| Payments To Acquire Leases Held For Investment | $69.0M |
| Payments Of Financing Costs | $342.8K |
| Net Cash Provided By Used In Investing Activities | -$69.0M |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q1 2025 | Q1 2024 |
|---|---|---|
| Net Cash Provided By Used In Operating Activities | -$281.9K | $0.00 |
| Increase Decrease In Accrued Liabilities | $22.3K | $3.1K |
| Increase Decrease In Prepaid Expense | $50.8K | $0.00 |
| Net Cash Provided By Used In Financing Activities | ||
| Proceeds From Sale Of Private Placement Units Including Over Allotment | ||
| Proceeds From Sale Of Longterm Investments | ||
| Payments To Acquire Leases Held For Investment | ||
| Payments Of Financing Costs | ||
| Net Cash Provided By Used In Investing Activities |
Per-Share & Share Counts
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2024 | FY2023 |
|---|---|---|
| Earnings Per Share Diluted | $2.67 | |
| Weighted Average Basic Shares Outstanding Pro Forma Non Redeemable Ordinary Shares | 1.8M | |
| Earnings Per Share Diluted Non Redeemable Ordinary Shares | $-1.13 | |
| Preferred Stock Shares Outstanding | 0.00 | |
| Preferred Stock Shares Issued | 0.00 | |
| Preferred Stock Shares Authorized | 10.0M | |
| Preferred Stock Par Or Stated Value Per Share | $0.00 | |
| Common Stock Shares Outstanding | 1.7M | |
| Common Stock Shares Issued | 1.7M | |
| Common Stock Shares Authorized | 490.0M | |
| Common Stock Par Or Stated Value Per Share | $0.00 | |
| Weighted Average Number Of Diluted Shares Outstanding Redeemable Ordinary Shares | 805.5K | |
| Weighted Average Number Of Diluted Shares Outstanding |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 |
|---|---|---|---|---|---|---|---|---|
| Earnings Per Share Diluted | $0.09 | $0.05 | $0.08 | $0.00 | $0.00 | $0.00 | $0.00 | |
| Weighted Average Basic Shares Outstanding Pro Forma Non Redeemable Ordinary Shares | 2.2M | 2.2M | 2.2M | 1.5M | 1.7M | 1.7M | ||
| Earnings Per Share Diluted Non Redeemable Ordinary Shares | $-0.01 | $-0.06 | $-0.03 | $-0.02 | $-0.01 | $0.00 | ||
| Preferred Stock Shares Outstanding | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Preferred Stock Shares Issued | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Preferred Stock Shares Authorized | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M | |||
| Preferred Stock Par Or Stated Value Per Share | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | |||
| Common Stock Shares Outstanding | 2.2M | 2.2M | 2.2M | 2.2M | 1.7M | |||
| Common Stock Shares Issued | 2.2M | 2.2M | 2.2M | 2.2M | 1.7M | |||
| Common Stock Shares Authorized | 490.0M | 490.0M | 490.0M | 490.0M | 490.0M | |||
| Common Stock Par Or Stated Value Per Share | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | |||
| Weighted Average Number Of Diluted Shares Outstanding Redeemable Ordinary Shares | 6.9M | 6.9M | 6.9M | 0.00 | ||||
| Weighted Average Number Of Diluted Shares Outstanding | 1.5M | 1.5M |
Other Metrics
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2024 | FY2023 |
|---|---|---|
| Operating Costs And Expenses | $201.7K | |
| Investment Income Interest And Dividend | $344.5K | |
| Prepaid Expense Current | $0.00 | |
| Additional Paid In Capital | $24.8K | |
| Subsequent Accretion Of Carrying Value For Public Shares To Redemption Value | 344.5K | |
| Due To Related Party Current | $0.00 | |
| Initial Accretion Of Carrying Value To Redemption Value | -$2.7M | |
| Shares Subject To Mandatory Redemption Settlement Terms Number Of Shares | ||
| Shares Subject To Mandatory Redemption Settlement Terms Amount | ||
| Related Party Transactions Amounts Due To Related Party | ||
| Reclassification Of Ordinary Shares Subject To Redemption | 68.1M | |
| Issuance Of Representative Shares | 341.6K | |
| Initial Accretion Of Carrying Value For Public Shares To Redemption Value | 2.7M | |
| Founder Share Issued To Initial Shareholder Amount | ||
| Allocation Of Offering Costs To Ordinary Shares Subject To Redemption | 1.8M | |
| Underwriters Discount | -$1.0M | |
| Subsequent Accretion Of Carrying Value To Redemption Value | -$344.5K | |
| Sale Of Public Units Through Public Offering Including Over Allotment Amount | $69.0M | |
| Sale Of Private Placement Units Over Allotment Amount | $135.0K | |
| Sale Of Private Placement Units Amount | $2.0M | |
| Reclassification Of Ordinary Shares Subject To Redemption Amount | -68.1M |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Costs And Expenses | $124.5K | $509.2K | $253.5K | $33.6K | $8.0K | $3.1K | $0.00 | |||
| Investment Income Interest And Dividend | $739.6K | $730.4K | $726.1K | $0.00 | $0.00 | $0.00 | ||||
| Prepaid Expense Current | $55.8K | $90.1K | $124.3K | $73.5K | $41.2K | |||||
| Additional Paid In Capital | $0.00 | $0.00 | $0.00 | $312.0K | $24.8K | |||||
| Subsequent Accretion Of Carrying Value For Public Shares To Redemption Value | 726.1K | 0.00 | ||||||||
| Due To Related Party Current | $254.5K | $254.5K | $254.5K | $254.5K | ||||||
| Initial Accretion Of Carrying Value To Redemption Value | -$739.6K | -$730.4K | -$726.1K | |||||||
| Shares Subject To Mandatory Redemption Settlement Terms Number Of Shares | 6.9M | 6.9M | 6.9M | 6.9M | ||||||
| Shares Subject To Mandatory Redemption Settlement Terms Amount | 71.5M | 70.8M | 69.3M | |||||||
| Related Party Transactions Amounts Due To Related Party | $197.2K | $0.00 | ||||||||
| Reclassification Of Ordinary Shares Subject To Redemption | ||||||||||
| Issuance Of Representative Shares | ||||||||||
| Initial Accretion Of Carrying Value For Public Shares To Redemption Value | ||||||||||
| Founder Share Issued To Initial Shareholder Amount | $0.00 | |||||||||
| Allocation Of Offering Costs To Ordinary Shares Subject To Redemption | ||||||||||
| Underwriters Discount | ||||||||||
| Subsequent Accretion Of Carrying Value To Redemption Value | ||||||||||
| Sale Of Public Units Through Public Offering Including Over Allotment Amount | ||||||||||
| Sale Of Private Placement Units Over Allotment Amount | ||||||||||
| Sale Of Private Placement Units Amount | ||||||||||
| Reclassification Of Ordinary Shares Subject To Redemption Amount |
Most recent annual filing with the SEC: March 27, 2025
Data sourced from SEC EDGAR public filings as of August 5, 2026.